Blue Water Vaccines, Inc. (BWV)


-0.02 (-9.07%)
Symbol BWV
Price $0.2455
Beta 0.000
Volume Avg. 0.12M
Market Cap 4.375M
Shares () -
52 Week Range 0.181-1.95
1y Target Est -
DCF Unlevered BWV DCF ->
DCF Levered BWV LDCF ->
ROE -111.44% Strong Sell
ROA -65.34% Strong Sell
Operating Margin -
Debt / Equity 126.22% Buy
P/E -0.23 Neutral
P/B 0.42 Neutral


Consensus EPS

Upgrades & Downgrades

Latest BWV news

Dr. Neil J. Campbell MA, MBA
NASDAQ Capital Market

Blue Water Vaccines, Inc., a biotechnology company, engages in the research and development of vaccines to prevent infectious diseases worldwide. The company's lead vaccine programs that are under preclinical development include BWV-101, an influenza vaccine; and BWV-102, a H1 pre-pandemic vaccine. It also has other pipeline under preclinical development comprising BWV-201, a streptococcus pneumoniae induced acute otitis media vaccine program; BWV-301, a norovirus-rotavirus vaccine program; and BWV-302, a norovirus-malaria vaccine program. The company was incorporated in 2018 and is based in Cincinnati, Ohio.